Glutamatergic Dysfunctioning in Alzheimer's Disease and Related Therapeutic Targets

Journal of Alzheimer's Disease - Netherlands
doi 10.3233/jad-132621
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IOS Press

Related search

Microglial Inflammation and Phagocytosis in Alzheimer's Disease: Potential Therapeutic Targets

British Journal of Pharmacology
Pharmacology
2019English

Therapeutic Perspectives in Alzheimer's Disease

Recent Patents on CNS Drug Discovery
PsychiatryDrug DiscoveryMental HealthPharmacology
2012English

Aβ-Degrading Enzymes: Modulators of Alzheimer's Disease Pathogenesis and Targets for Therapeutic Intervention

Biochemical Society Transactions
Biochemistry
2005English

Therapeutic Targets: MTOR and Related Pathways

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2006English

Alzheimer's Disease and Related Conditions

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1972English

Is the Neuronal Basis of Alzheimer's Disease Cholinergic or Glutamatergic?

FASEB Journal
BiochemistryBiotechnologyGeneticsMolecular BiologyMedicine
1990English

MOLECULAR DOCKING STUDIES ON THE THERAPEUTIC TARGETS OF ALZHEIMER'S DISEASE (AChE AND BChE) USING NATURAL BIOACTIVE ALKALOIDS

International Journal of Pharmacy and Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2016English

Novel Therapeutic Targets in Inflammatory Bowel Disease

Prescriber
Pharmacology
2019English

The Characterization of Microtubule-Stabilizing Drugs as Possible Therapeutic Agents for Alzheimer's Disease and Related Tauopathies

Pharmacological Research
Pharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy